Compositions and methods for diagnosis and treatment of type 2 diabetes
First Claim
Patent Images
2. An isolated nucleic acid sequence encoding an amino acid sequence selected from the group consisting of SEQ ID NO:
- 1, SEQ ID NO;
2, and SEQ ID NO;
3.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates generally to the identification of biological markers associated with an increased risk of developing Diabetes, as well as methods of using such biological markers in diagnosis and prognosis of Diabetes. The biological markers of the invention may indicate new targets for therapy or constitute new therapeutics for the treatment or prevention of Diabetes.
-
Citations
6 Claims
-
2. An isolated nucleic acid sequence encoding an amino acid sequence selected from the group consisting of SEQ ID NO:
- 1, SEQ ID NO;
2, and SEQ ID NO;
3.
- 1, SEQ ID NO;
-
4-1. A method of inhibiting one or more kinases in a cell, comprising contacting the cell with the isolated peptide of claim 1.
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeAmerican Type Culture Collection
-
Original AssigneeAmerican Type Culture Collection
-
InventorsIkonomi, Pranvera, Gelber, Cohava, Liu, Liping, Xie, Zhidong, Auge, Catherine R., Simms, John R.
-
Application NumberUS12/319,883Publication NumberTime in Patent OfficeDaysField of SearchUS Class Current514/1.100CPC Class CodesA61P 3/10 for hyperglycaemia, e.g. an...C12Q 1/6883 for diseases caused by alte...C12Q 2600/118 Prognosis of disease develo...C12Q 2600/158 Expression markers
